跳至主要内容
临床试验/ISRCTN98332431
ISRCTN98332431已完成1 期

Phase I Trial: Quotient Code QSC300535

Rare Thyroid Therapeutics International AB0 个研究点目标入组 45 人开始时间: 2023年4月25日最近更新:
适应症

试验速览

阶段
1 期
状态
已完成
入组人数
45

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
Male

入选标准

  • The sponsor has confirmed that the trial meets the criteria for deferral of publication of the full details of the trial. The full details will be added to the study record within 30 months after the trial has ended.

排除标准

  • The sponsor has confirmed that the trial meets the criteria for deferral of publication of the full details of the trial. The full details will be added to the study record within 30 months after the trial has ended.

研究者

相似试验